Only 4% of Nordic companies see meaningful ROI from AI, despite it being a top strategic priority. BCG’s March 2026 report flags a widening gap between ambition and execution, with deployment infrastructure lagging behind research output. Chalmers’ precision health initiative in Western Sweden shows the pattern: breakthroughs in AI and biotech are piling up, but the pipelines to market are thin. Finland’s push to avoid another Nokia-style loss in AI underscores the urgency, yet the region’s focus remains on publication, not productization. Builders here are sitting on methods that hold up, but the bridge to value is missing. This week, audit one research project for its path to deployment. If it lacks a clear route to market, reallocate resources to infrastructure or partnerships that do.

researched · 3 sources

25 SepResearchreaches nearby